BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16390270)

  • 1. Fusion of the human immunodeficiency virus type 1 tat protein transduction domain to thymidine kinase increases bystander effect and induces enhanced tumor killing in vivo.
    Tasciotti E; Giacca M
    Hum Gene Ther; 2005 Dec; 16(12):1389-403. PubMed ID: 16390270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcellular transfer of active HSV-1 thymidine kinase mediated by an 11-amino-acid peptide from HIV-1 Tat.
    Tasciotti E; Zoppè M; Giacca M
    Cancer Gene Ther; 2003 Jan; 10(1):64-74. PubMed ID: 12489030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tat8-TK/GCV suicide gene therapy induces pancreatic tumor regression in vivo.
    Cascante A; Huch M; Rodríguez LG; González JR; Costantini L; Fillat C
    Hum Gene Ther; 2005 Dec; 16(12):1377-88. PubMed ID: 16390269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
    Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
    Tang Q; Zhang D; Wan M; Jin L
    Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy.
    Rautsi O; Lehmusvaara S; Ketola A; Määttä AM; Wahlfors J; Pellinen R
    Cancer Gene Ther; 2008 May; 15(5):303-14. PubMed ID: 18309353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of lentivirus-mediated and MUC1 antibody-targeted VP22-TK/GCV suicide gene therapy for ovarian cancer.
    Kong B; Wang W; Liu C; Song L; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Wang B; Wei MQ; Yang Q
    In Vivo; 2003; 17(2):153-6. PubMed ID: 12792977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
    Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro and in vivo bystander effect of adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene].
    Gao G; Huang T; Chen S
    Zhonghua Wai Ke Za Zhi; 2002 Apr; 40(4):301-3. PubMed ID: 12133366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tegument viral protein 22 enhanced cell-killing effect of the herpes simplex virus thymidine kinase/ganciclovir system on ovarian cancer in vivo].
    Kong BH; Wang WX; Liu CS; Ma DX; Qu X
    Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):195-8. PubMed ID: 12885362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
    Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
    Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S
    Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of a combination of ponicidin and acyclovir/ganciclovir to the antitumor efficacy of the herpes simplex virus thymidine kinase gene therapy system.
    Hayashi K; Hayashi T; Sun HD; Takeda Y
    Hum Gene Ther; 2002 Feb; 13(3):415-23. PubMed ID: 11860708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.
    Kokoris MS; Sabo P; Adman ET; Black ME
    Gene Ther; 1999 Aug; 6(8):1415-26. PubMed ID: 10467366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma.
    Ryu CH; Park KY; Kim SM; Jeong CH; Woo JS; Hou Y; Jeun SS
    Biochem Biophys Res Commun; 2012 May; 421(3):585-90. PubMed ID: 22525671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular localization and sustained prodrug cell killing activity of TAT-HSVTK fusion protein in hepatocelullar carcinoma cells.
    Cao L; Si J; Wang W; Zhao X; Yuan X; Zhu H; Wu X; Zhu J; Shen G
    Mol Cells; 2006 Feb; 21(1):104-11. PubMed ID: 16511352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
    Wildner O; Blaese RM; Morris JC
    Hum Gene Ther; 1999 Nov; 10(16):2679-87. PubMed ID: 10566896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
    Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
    Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.